Effects of interleukin-2 treatment on CD1d-restricted natural killer T cells.
Sandberg
Johan K
JK
Moll
Markus
M
D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000276:immunology; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000276:immunology*
D007376:Interleukin-2